[1] Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Cheson D., Fisher R.I., Barrington S.F., et al_J Clin Oncol, 32 (2014), pp. 3059-3068.
[2] Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Barrington S.F., Mikhaeel N.G., Kostakoglu L., et al._J Clin Oncol, , 32 (2014), pp. 3048-3058.
[3] Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up on behalf of the ESMO Guidelines Committee. Eichenauer D. A., Aleman B. M. P., Andre´ M., et al_ Annals of Oncology 29 (Supplement 4): iv19–iv29, 2018.
[4] Siegel MJ. Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol Clin North Am 2001; 39: 701-20.
[5] Fleming JB, Cantor SB, Varma DG, et al. Utility of chest computer tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 2001; 92: 863-8.
[6] Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. P. G. Casali1 , N. Abecassis2 , S. Bauer et al. Annals of Oncology 29 (Supplement 4): iv51–iv67, October 2018
[7] Competitive advantage of PET/MRI. Jadvar H, Colletti PM_Eur J Radiol. 2013.
[8] 18F-FDG-PET/MRI in lymphoma patients. Ferdová E, Ferda J, Baxa J_ Eur J Radiol. 2017.
[9] Pediatric Oncologic Imaging: A Key Application of Combined PET/MRI. Gatidis S, La Fougère C, Schaefer J.F_Fortschr Röntgenstr 2016; 188: 359–364.
[10] PET-MRI: clinical application of the new hybrid technology. Tudisca C, Nasoodi A, Fraioli F. Nuclear Medicine Communications 2015, 36:666–678.
[11] Diagnostic value of combined 18F-FDG PET/MRI for staging and restaging in paediatric oncology. Pfluger T, Melzer HI, Mueller WP et al_Eur J Nucl Med Mol Imaging (2012) 39:1745–1755.
[12] Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Ponisio MR, McConathy J, Laforest R et al_Pediatr Radiol 2016.
[13] Solid tumors in children. Kline N, Sevier N, et al _Journal of Pediatric Nursing. April 2013.
[14] Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. Buchbender C, Heusner TA, Lauenstein TC et al. J. Nucl. Med. 53 (8) (2012) 1244–1252.
[15] 18F-fluorodeoxyglucose PET/MR imaging in lymphoma. I. Platzek. PET Clin. 11 (4) (2016) 363–373.
[16] How PET/MR Can Add Value For Children With Cancer. Heike Daldrup-Link. Curr Radiol Rep. 2017 Mar; 5(3): 15. Published online 2017 Feb 21.
[17] PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Hirsch FW, Sattler B, Sorge I, et al. Pediatr Radiol. 2013;43(7):860
[18] Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Schafer JF, Gatidis S, Schmidt H, et al. Radiology. 2014;273(1):220–31.
[19] Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Ponisio MR, McConathy J, Laforest R, et al. Pediatr Radiol. 2016;46(9):1258–68.
[20] Potential Pediatric Applications of PET/MR. Purz S, Sabri O, Viehweger A, et al_J Nucl Med. 2014;55 (Supplement 2):32S–9S.